The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of afatinib in combination with nimotuzumab in non-small cell lung cancer patients with acquired resistance to gefitinib or erlotinib.
 
Myung-Ju Ahn
No Relationships to Disclose
 
Ji Yun Lee
No Relationships to Disclose
 
Jong-Mu Sun
No Relationships to Disclose
 
Bo Mi Ku
No Relationships to Disclose
 
Jiae Koh
No Relationships to Disclose
 
Sung Hee Lim
No Relationships to Disclose
 
Min-Young Lee
No Relationships to Disclose
 
Haesu Kim
No Relationships to Disclose
 
Jin Seok Ahn
No Relationships to Disclose
 
Keunchil Park
No Relationships to Disclose